tbuckley/cabot-search huggingface dataset:
Thyroid
Journal: JAMA (2001)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Instability of Medical Interests Dependent on Municipal or County Politics.
Journal: JAMA (1885)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Errors in Text
Journal: JAMA Network Open (2020)

In the Invited Commentary titled "Are Observational, Real-World Studies Suitable to Make Cancer Treatment Recommendations?" 1 published July 30, 2020, there were errors in 6 parts of the text where the terms propensity score-matched and propensity score-matching were incorrectly used.The terms should have instead been propensity-weighted and propensity score-weighting, respectively.This article has been corrected.
Glyphosate Results Revisited: De Roos et al. Respond
Authors: Anneclaire J. De Roos, Megan A. Svec, Aaron Blair, Jennifer A. Rusiecki, Mustafa Dosemeci, Michael C. Alavanja, Jane A. Hoppin, Dale P. Sandler
Journal: Environmental Health Perspectives (2005)

Arsenic on the Hands of Children Kwon et al. (2004) reported significantly elevated dislodgeable soluble arsenic loads on (one or both?) hands of children following play on structures treated with chromated copper arsenate (CCA) but then concluded that the observed difference is unimportant:With a safe conservative assumption that all the arsenic on children's hands is ingested, the measured value is below the estimated average daily intake of inorganic arsenic from water and food ….
Increased Risk of Monoclonal Gammopathy in First-Degree Relatives of Patients with Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance.
Authors: Celine M Vachon, Robert Kyle, Terry Therneau, Dirk R Larson, Colin Colby, Barbara J Foreman, Angela Dispenzieri, Shaji Kumar, Jerry Katzmann, S. Vincent Rajkumar
Journal: Blood (2008)
Annual Report of the Supervising Surgeon-General of the Marine-Hospital Service
Journal: JAMA (1889)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Passive Euthanasia
Authors: J. L. VINCENT
Journal: Annals of Internal Medicine (1980)

Letters and Corrections1 June 1980Passive EuthanasiaJ. L. VINCENT, M.D.J. L. VINCENT, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-92-6-865_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: In the January issue, Lo and Jonsen (1) exposed clearly the problems of euthanasia. The ethical questions, very well defined by them, are expressed in similar words everywhere in the world. In the intensive-care unit, the "right to die" can present somewhat different aspects when life is depending only on heavy technical support. Communication with these critically ill patients is almost always impossible, and the opinion of the family is generally inconsistent.When I served a 2-year fellowship in critical care in the United States, I was one of five foreign physicians (from Israel, France, Spain, Holland,...References1. LOJONSEN BA. Ethical decisions in the care of a patient terminally ill with metastatic cancer. Ann Intern Med. 1980;92:107-11. LinkGoogle Scholar2. RACHELS J. Active and passive euthanasia. N Engl J Med. 1975;292:78-80. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: University Hospital Erasme Free University of Brussels Brussels Belgium PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 June 1980Volume 92, Issue 6Page: 865-865KeywordsCritical careEuthanasiaFellowships Issue Published: 1 June 1980 PDF DownloadLoading ...
Reply to Letter to the Editor in response to “Skin Biopsy in the Diagnosis of Intravascular Lymphoma: A Retrospective Diagnostic Accuracy Study”
Authors: Joe K. Tung, Daniel Rozenbaum, Renajd Rrapi, Sidharth Chand, Yun Xue, Mai P. Hoang, Daniela Kroshinsky
Journal: Journal of the American Academy of Dermatology (2021)
WASHINGTON NEWS
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Evaluation of Feasibility of Mutagenic Testing of Shale Oil Products and Effluents
Authors: J. L. Epler, T. K. Rao, M. R. Guerin
Journal: Environmental Health Perspectives (1979)

In an effort to gather preliminary information on the potential genetic hazards of proposed or existing oil shale technologies, we have begun a correlated analytical and genetic analysis of a number of test materials. The work is divided into two phases: one deals with known compounds expected to occur in the environment through shale oil production or use; the other deals with actual samples from existing or experimental processes. A fractionation procedure has been applied to crude product and aqueous product material from an oil shale process. Mutagenicity of the various fractions was assayed by using reversion of histidine-requiring auxotrophs of Salmonella typhimurium (strain TA100, base-substitution mutant; TA98 and TA1537, frameshift mutants). In order to incorporate metabolic activation of these fractions and compounds, we used liver homogenates (S-9) from rats induced with Aroclor 1254 in the standard plate assay. Preliminary results implicate chemical constituents of these fractions (identified or predicted) were tested individually for their mutagenic activity and correlated with the genetic monitoring.
Gulstonian Lectures on Fever and Inflammation
Authors: W. Addison
Journal: BMJ (1859)

great relief to the breathing.The sulphate of copper was con- tinued at longer intervals for thirty-six hours, together with beef tea, port wine, etc.July 10th.He was much improved.July 17th.The improvement continued.The sulphate of copper was given once every four or six hours: sickness fol- lowed each dose, with more or less detachment of membrane.Hlis swallowing being now more free, beef-tea and port wine wrere given largely; anid this day he was prevailed on to use the following gargle: & Acidi hydrochlorici nlxv; mellis rosm 3ss; aqut 3v.M.From this time he gradually improved, and would have been soon convalescent, but for considerable sloughing of the ex- ternal fore part of the throat, that lhad taken place from the vesicating application used at the onset, so that he was not off my hands, quite well, until August 2nd.His mother, a young widow, who was in constant attendance upon him, had a smart attack of sore-throat, evidently of the same character, but of a slig,hter degree; it was removed by the use of iydrochloric acid gargle, with external counterirritation on the throat, and saline aperients.lREMARKS.In the foregoing case, altlhough little had been made public at that time of diplhtheria, and ino case of the dis.ease had previously come under my notice, I had no doubt that it was a more formidable disease of the throat than I bad met with for some time, if I except cases of croup.From the intractable state of the little patient, there was not a good chance of using remedies; and although, from having seen many milder cases since, in whichi the tincture of sesqtLi- chloride of iron has appeared of service, yet I feel certain that the sulphate of copper saved this child's life, as I have fre- quently found in severe and hopeless oroup cases, and wbich, I think, is worth a trial where other remedies faiL There was in this case no evidence of contagion; scarlatina was not pre- valent in the neighbourhood; nor was there affection of any in- ternal organs.1lxstirnian cdxutts FEVER AND INFLAMMATION.
Early Dementia
Authors: G. W. B. James
Journal: BMJ (1951)

As a social phenomenon premature or early dementia constitutes one of the major tragedies seen by medical men.It seems unbelievable that a man apparently in the prime of life should suddenly begin to fail to find the names of common objects or take to wandering aimlessly in the streets around his home, or that the housewife should become incapable of managing a familiar household or be unable to find her home on returning from shopping.Even worse is the failure of judgment in social, professional, or business matters so that the sufferer makes mistakes in habitual work which may invoLve a family in distress or ruin.This same
OBITUARY
Journal: British Journal of Dermatology (1946)

British Journal of DermatologyVolume 58, Issue 7-8 p. 192-192 Free Access OBITUARY First published: July 1946 https://doi.org/10.1111/j.1365-2133.1946.tb11236.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume58, Issue7-8July 1946Pages 192-192 RelatedInformation
"International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343…
Authors: Kian Chung, Sally Wenzel, Jan Brozek, Andrew Bush, Mario Castro, Peter Sterk, Ian Adcock, Eric Bateman, Elisabeth Bel, Eugene Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar Jajour, Thais Mauad, Ronald Sorkness, W Gerald
Journal: European Respiratory Journal (2014)
Errors in Abstract and Figure
Journal: JAMA Network Open (2021)

Benoist Chibaudel, MD; Julie Henriques, MSc; Manel Rakez, MSc; Baruch Brenner, MD; Tae Won Kim, MD; Mercedes Martinez-Villacampa, MD; Javier Gallego-Plazas, MD; Andres Cervantes, MD; Katharine Shim, MD; Derek Jonker, MD; Veronique Guerin-Meyer, MD; Laurent Mineur, MD; Chiara Banzi, MD; Alice Dewdney, MD; Thitiya Dejthevaporn, MD; Haiko J. Bloemendal, MD; Arnaud Roth, MD, MD; Markus Moehler, MD; Enrique Aranda, MD; Eric Van Cutsem, MD; Josep Tabernero, MD; Hans-Joachim Schmoll, MD; Paulo M. Hoff, MD; Thierry André, MD; Aimery de Gramont, MD
Treatment INDs: research for hire?
Authors: G. P. Monaco
Journal: JAMA (1987)

THE FOOD and Drug Administration (FDA) has finalized new rules to facilitate the availability, outside of clinical trials, of promising new therapies being investigated in clinical trials. Effective June 22, 1987, investigational new drugs (INDs) have been available to treat "desperately" ill patients (those patients with serious or immediately life-threatening illnesses) as early in the drug development phase as possible. These new therapeutic options are referred to as "treatment INDs.<sup>1</sup>Patient access to these drugs, usually limited to clinical trials, is conditioned on an absence of comparable or satisfactory therapy and on adequate enrollment in ongoing clinical trials. The FDA postulates that requiring adequate clinical trial enrollment before access to treatment INDs is permitted will prevent the undermining of the clinical trial process. Only time will tell whether the trial process will be harmed. However, without this provision, not included in the rule as initially proposed, the FDA would have
Your Diabetes: A Complete Manual for Patients
Journal: JAMA (1952)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Fully implanted left ventricular assist device may enter clinical trials early in 1991
Authors: M. F. Goldsmith
Journal: JAMA (1990)

NEW HEART is the literal meaning of Novacor, and a group at Stanford (Calif) University School of Medicine that has been using this firm's left ventricular assist system in patients for 6 years believes the device is now ready to fully live up to its name. A spokesperson for the Novacor Corporation, Oakland, Calif (part of the Baxter Health Care Corporation), says the initial phase of the planned trial of the implantable device will be under the auspices of the National Heart, Lung, and Blood Institute, Bethesda, Md. Site selection is now under way, and it is hoped the trial will start early in 1991. At the American Association for Thoracic Surgery meeting in Toronto, Canada, Patrick M. McCarthy, MD (who participated in the study as a surgical fellow at Stanford and who is now a cardiac surgeon at the Cleveland Clinic in Ohio), agreed that clinical trials of the
Effects of 48 F (8.9 C) and 83 F (28.4 C) on Longevity and Pathology of Male Rats
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
An Address Delivered at the Opening of the Section of Psychology
Authors: D. Yellowlees
Journal: BMJ (1885)

but " there is much land yet to be possessed."I look forward, with fond anticipation, to a period (although I shall not see it) when scarlet fever, small-pox, and other zymotics, will be as much mere matters of history as the great plague and sweating-sickness in England ; when he assurability of human life will be confined to a very narrow range, the central point of which will be 100 years.These are bright anticipations; but, having regard to our progress in the past, they are, as I conceive, not altogether visionary.In an- ticipating such a happy consummation, which we, especially in this Section, are endeavouring to hasten, the words of the old song, which I used to sing when a youth, recur to my mind- "There is a good time coming, boys;We may not live to see the day, But earth shall glisten in the ray Of the good time coming."
Using a collaborative approach for rapid deployment of advance care planning in the outpatient oncology setting.
Authors: Jane Alcyne Severson, Jeffrey B. Smerage, Jamie Lindsay, Laura Petersen, Keith Mark Swetz, Arif Kamal
Journal: Journal of Clinical Oncology (2016)

e18192 Background: The Michigan Oncology Quality Consortium (MOQC) is a quality collaborative supported by Blue Cross Blue Shield of Michigan with the goal of improving cancer care in Michigan by using data gathered as part of the national Quality Oncology Practice Initiative (QOPI) program. In spring 2014, MOQC launched a statewide collaborative focused on advance care planning (ACP) with the following aim: to provide training and resources on how to engage patients in a discussion of goals, preferences, and priorities for care. Methods: The collaborative was comprised of three half day learning sessionsthat included an overview of legal and documentation requirements, and facilitator-lead role play with patient actors. Lean resources (templates, workflows) to support standard work in the clinic were disseminated. Eight oncology practices participated ranging in size from 1-25 physicians. ASCO QOPI data were analyzed pre and post collaborative in spring 2014 and spring 2015. Results: Improvement in QOPI performance from spring 2014 to 2015 on “hospice enrollment, palliative care referral/services, or documented discussion” (73.8% to 77.6%) and “for patients not referred, hospice or palliative care discussed within the last 2 months of life” (17.7% to 23.9%) was noted for participating practices (n = 8). Collaborative participants also compared favorably to all other MOQC practices (n = 47) in spring 2015 on “hospice enrollment, palliative care referral or documented discussion” (77.6% vs. 66.2%, p < 0.001). Conclusions: Use of a collaborative education modelthat includes facilitator-lead role play and dissemination of lean resources to create standard work may be an efficient and effective approach to improve discussion and documentation of advance care planning.
Current therapy of gonorrhea
Journal: JAMA (1971)

Dr. Steven Raffin, Senior Assistant Resident in Medicine, the Jewish Hospital of St. Louis and Assistant in Medicine, Washington University School of Medicine: A 27-year-old woman was hospitalized with acute migratory polyarthritis of four days' duration. She had noted the abrupt onset of right wrist stiffness, followed by swelling and erythema of the right elbow, left fourth and fifth metacarpophalangeal joints, right shoulder, left elbow, and both knees. Four days prior to these symptoms, she had noted a profuse, white vaginal discharge. One day before entry, pustules surrounded by erythema had appeared over the medial base of both thumbs. Her only medication at the time of admission consisted of oral contraceptive tablets. Twice previously, she had been treated for gonorrhea, most recently six months before. On physical examination, the patient was anxious but not severely ill. The blood pressure was 100/70 Hg; pulse rate, 100 beats per minute and regular;